America’s Vacation Was Built on Gluttony. Ozempic Killed the Buzz.
Summary
Weight-loss drugs like Ozempic are changing consumer behavior, potentially impacting travel spending. The U.S. obesity rate dropped from 40% in 2022 to 37% in 2025 due to these medications. This shift could lead to decreased spending on food and alcohol while traveling, affecting the travel industry.